BFRI News and Press, Biofrontera Inc. From 05/12/23

Conference call begins at 8:30 a.m. Eastern time today WOBURN, MA / ACCESSWIRE / May 12, 2023 / Biofrontera Inc. (Nasdaq:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, today reported financial results for the three months en...

2023-05-12 07:22:47 ET Biopharmaceutical company specializing in the commercialization of dermatologic products, Biofrontera ( NASDAQ: BFRI ) announces the resignation of Erica Monaco as CEO, which will be effective pending the completion of a near term transition of resp...

Executive Chairman Hermann Luebbert to Assume CEO Responsibilities, Reaffirms the Company's Strategic Plan and 2023 Commercial Goals WOBURN, MA / ACCESSWIRE / May 12, 2023 / Biofrontera Inc. (Nasdaq:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of d...

2023-05-11 09:36:33 ET Biofrontera ( NASDAQ: BFRI ) has secured a $6.5 million line of credit from MidCap Business Credit, the biopharma company said on Thursday. The company said funds from the credit line will be used to support its working capital changes accordi...

WOBURN, MA / ACCESSWIRE / May 11, 2023 / Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced that it has entered into a $6.5 million secured line of credit with MidCap Business Credit, LLC, subject to the b...

WOBURN, MA / ACCESSWIRE / May 9, 2023 / Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced that as part of several Skin Cancer Awareness Month activities taking place throughout the month of May, it is c...

WOBURN, MA / ACCESSWIRE / March 27, 2023 / Biofrontera Inc. (NASDAQ:BFRI) , a biopharmaceutical company specializing in the commercialization of dermatological products, today announced that it is executing on the company's stated plans to invest in and meaningfully grow its' salesforce in 2023...

Providing live demonstrations of a PDT procedure using the RhodoLED ® lamp at booth #2224 WOBURN, MA / ACCESSWIRE / March 17, 2023 / Biofrontera Inc. (NASDAQ:BFRI) , a biopharmaceutical company specializing in the commercialization of dermatological products, today announced that it w...

This press release corrects and replaces the press release published on 3/8/2023 at 4:03:00 PM ET, as the Adjusted EBITDA Reconciliation table was not included in all previously posted versions of the press release. WOBURN, MA / ACCESSWIRE / March 9, 2023 / Biofrontera, Inc. (NASDAQ:BFRI) , ...

2023-03-08 23:09:04 ET Biofrontera, Inc. (BFRI) Q4 2022 Earnings Conference Call March 08, 2023, 04:30 PM ET Company Participants Erica Monaco - CEO, COO, Treasurer & Secretary Fred Leffler - CFO Conference Call Participants Jonathan Aschoff - ROTH Ca...